Tevogen Bio Holdings Inc. announced the relocation of its corporate headquarters to Warren, New Jersey, more than doubling its previous space. The move centralizes key teams, including research and regulatory affairs, and supports the Tevogen.AI initiative. CEO Ryan Saadi personally contributed $500,000 towards the facility's build-out and first-year operations, underscoring leadership's commitment to advancing accessible, affordable cell therapies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.